Nomura Holdings’s Roivant Sciences ROIV Stock Holding History

Nomura Holdings’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-73,600	Closed	-$1.11M	–	2123
2025 Q3	$1.11M	Buy	+73,600	New	+$911K	﹤0.01%	1360
2024 Q4	–	Sell	-52,500	Closed	-$606K	–	2366
2024 Q3	$606K	Buy	+52,500	New	+$598K	﹤0.01%	1225

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nomura Holdings's ROIV Position: Q1 2026 in Review

Nomura Holdings sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 25,706 shares — an estimated $558K sold.

Nomura Holdings first reported a position in ROIV in Q2 2024 and held it in 3 quarters. The position peaked at $674K in Q4 2024. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Nomura Holdings reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
Nomura Holdings sold 25,706 Roivant Sciences shares in Q1 2026, an estimated $558K.
Nomura Holdings first reported a position in Roivant Sciences in Q2 2024 and held it in 3 quarters.
Nomura Holdings's Roivant Sciences position peaked at $674K in Q4 2024.
440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.